Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors.

The FDA has expanded the approval of Baqsimi nasal powder to include treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.

ATTD conference, experts debated whether patients who use continuous glucose monitoring should aim for normal glycemia.

For many people, injection needles can be scary – and the larger ones for specialized longer-term medications are far more ...

An estimated 1 in 10 people worldwide have diabetes. Africa is the region with the fastest growth and it's estimated that the ...

Investigators have developed a long-acting contraceptive implant that can be delivered through tiny needles to minimize patient discomfort and increase the likelihood of medication use. Their findings ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

I’m a lesbian in my mid-20s, and I have been with my partner for about two and a half years now. We are non-monogamous (we date and sleep with other people, but see each other as primary partners), ...

A Utah nurse killed a woman using insulin to collect life insurance money. The nurse offered to help the woman end her life ...

A new study by researchers at the Department of Instrumentation and Applied Physics (IAP), Indian Institute of Science (IISc) offers an alternative solution via a technique called photoacoustic ...

The latest trend in health and fitness tracking may sound familiar: wearing continuous glucose monitors (CGMs). Many people ...

The innovative photoacoustic sensing method developed at IISc allows for precise, non-invasive glucose measurement, improving ...